Kim SY - Search Results

1

PMFF: Development of a Physics-Based Molecular Force Field for Protein Simulation and Ligand Docking.

Hwang SB, Lee CJ, Lee S, Ma S, Kang YM, Cho KH, Kim SY, Kwon OY, Yoon CN, Kang YK, Yoon JH, Nam KY, Kim SG, In Y, Chai HH, Acree WE Jr, Grant JA, Gibson KD, Jhon MS, Scheraga HA, No KT. Hwang SB, et al. Among authors: kim sg, kim sy. J Phys Chem B. 2020 Feb 13;124(6):974-989. doi: 10.1021/acs.jpcb.9b10339. Epub 2020 Jan 29. J Phys Chem B. 2020. PMID: 31939671 Free PMC article.

2

Regioselectivity prediction of CYP1A2-mediated phase I metabolism.

Jung J, Kim ND, Kim SY, Choi I, Cho KH, Oh WS, Kim DN, No KT. Jung J, et al. Among authors: kim nd, kim sy, kim dn. J Chem Inf Model. 2008 May;48(5):1074-80. doi: 10.1021/ci800001m. Epub 2008 Apr 16. J Chem Inf Model. 2008. PMID: 18412330

3

Discovery of Novel Anti-prion Compounds Using In Silico and In Vitro Approaches.

Hyeon JW, Choi J, Kim SY, Govindaraj RG, Jam Hwang K, Lee YS, An SS, Lee MK, Joung JY, No KT, Lee J. Hyeon JW, et al. Among authors: kim sy. Sci Rep. 2015 Oct 9;5:14944. doi: 10.1038/srep14944. Sci Rep. 2015. PMID: 26449325 Free PMC article.

4

Structural insight into the antiprion compound inhibition mechanism of native prion folding over misfolding.

Choi J, Govindaraj RG, Hyeon JW, Lee K, Ma S, Kim SY, Lee J, No KT. Choi J, et al. Among authors: kim sy. Chem Biol Drug Des. 2017 Jun;89(6):907-917. doi: 10.1111/cbdd.12916. Epub 2017 Feb 6. Chem Biol Drug Des. 2017. PMID: 27933736

5

3-D-QSAR study and molecular docking of methionyl-tRNA synthetase inhibitors.

Kim SY, Lee J. Kim SY, et al. Bioorg Med Chem. 2003 Dec 1;11(24):5325-31. doi: 10.1016/j.bmc.2003.09.044. Bioorg Med Chem. 2003. PMID: 14642576

6

Conformationally constrained analogues of diacylglycerol (DAG). Effect on protein kinase C (PK-C) binding by the isosteric replacement of sn-1 and sn-2 esters in DAG-lactones.

Kang JH, Chung HE, Kim SY, Kim Y, Lee J, Lewin NE, Pearce LV, Blumberg PM, Marquez VE. Kang JH, et al. Among authors: kim sy, kim y. Bioorg Med Chem. 2003 Jun 12;11(12):2529-39. doi: 10.1016/s0968-0896(03)00156-1. Bioorg Med Chem. 2003. PMID: 12757721

7

Macrocyclic diacylglycerol-bis-lactones as conformationally constrained analogues of diacylglycerol-lactones. Interactions with protein kinase C.

Kang JH, Kim SY, Lee J, Marquez VE, Lewin NE, Pearce LV, Blumberg PM. Kang JH, et al. Among authors: kim sy. J Med Chem. 2004 Jul 29;47(16):4000-7. doi: 10.1021/jm0497747. J Med Chem. 2004. PMID: 15267238

8

Deoxyribosyl analogues of methionyl and isoleucyl sulfamate adenylates as inhibitors of methionyl-tRNA and isoleucyl-tRNA synthetases.

Kim SE, Kim SY, Kim S, Kang T, Lee J. Kim SE, et al. Among authors: kim sy, kim s. Bioorg Med Chem Lett. 2005 Jul 15;15(14):3389-93. doi: 10.1016/j.bmcl.2005.05.035. Bioorg Med Chem Lett. 2005. PMID: 15951176

9

3D-QSAR analysis of conformationally constrained diacylglycerol (DAG) analogues as potent protein kinase C (PK-C) ligands.

Kim SY, Lee J. Kim SY, et al. Bioorg Med Chem. 2004 May 15;12(10):2639-44. doi: 10.1016/j.bmc.2004.03.016. Bioorg Med Chem. 2004. PMID: 15110845

10

2-Benzyl and 2-phenyl-3-hydroxypropyl pivalates as protein kinase C ligands.

Lee J, Lee JH, Kim SY, Perry NA, Lewin NE, Ayres JA, Blumberg PM. Lee J, et al. Among authors: kim sy. Bioorg Med Chem. 2006 Mar 15;14(6):2022-31. doi: 10.1016/j.bmc.2005.10.051. Epub 2005 Nov 15. Bioorg Med Chem. 2006. PMID: 16297629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12,060 results

Search Page